Xarelto Lawsuits: Uncontrollable Bleeding & Wrongful Death

Hundreds of complaints have already been filed across the United States against the manufacturers of Xarelto alleging that the drug caused uncontrollable bleeding which lead to serious injury or even death. Hundreds more are expected to be filed given the formation of a federal multidistrict litigation (MDL) group in Louisiana, and a mass tort group in the state courts of Pennsylvania to specifically administer claims from individuals and families that make similar allegations against Bayer AG and Johnson & Johnson.

Two cases have already been through trial. For an update on Xarelto lawsuit settlements, visit our settlements page.

How Many Xarelto Uncontrollable Bleeding Lawsuits Exist?

As of June 2017, there 18,000 lawsuits with a large portion of those having been transferred to the MDL in Louisiana and a smaller batch of lawsuits filed in Philadelphia, PA. However, there is expected to be thousands more out there when one looks at the incidence of internal bleeding events as suggested by the studies and the number of prescriptions and prevalence of Xarelto in the market.

Xarelto By The Numbers: Sales And Prescriptions

Shelevs of pharmacuetical drugsYou will likely have seen the heavy promotion of Xarelto on television, with Xarelto commercials that include famous golf players, and race car drivers. The complaints filed alleging that Xarelto caused internal bleeding injuries and death highlight the promotional techniques and market share captured by Xarelto.

In the first quarter of 2012 alone, Xarelto had issued 130,000 prescriptions in the United States. Xarelto also had reported sales of over 219 million euros in the EU. According to the EvaluatePharma in its World Preview, Xarelto will be the 19th best selling drug in the world and will generate 3.7 billion US Dollars in sales by 2018, which is up greatly from $596 million in 2012.

Xarelto is also a relatively expensive blood thinner when compared to Warfarin. A year’s supply of Xarelto costs $3,000 versus only $200 for the generic Warfarin.

Studies And Reports Linking Xarelto To Adverse Internal Bleeding Events

On April 24, 2014, the British Medical Journal published the results of a study which suggested that the risk of internal bleeding, and specifically a gastrointestinal bleed may double for patients who take Xarelto (Rivaroxaban) versus the generic version Warfarin. In the study, approximately 50,000 patients were evaluated. 1,649 took Xarelto and researchers stated that: “we cannot rule out a more than twofold higher risk of bleeding with [Xarleto] compared with Warfarin”.

Doctor looking at abdominal xrayAnother study performed by doctors from the Erasmus MC University Medical Center in Rotterdamn, The Netherlands performed a subgroup analysis on the risk of GI (gastrointestinal) bleeds comparing the new form of blood thinner which included Pradaxa and Xarelto versus the standard care versions such as Warfarin. As to Xarelto, the researchers found that there was a 1.49 times increase in the risk of internal bleeding versus Warfarin. The researchers in this study assessed many blood thinners and lamented the fact that the Xa inhibitor class, including Xarelto, lacked an antidote.

On January 16, 2015 a new study was released by Baylor College of Medicine which was funded by Bayer Healthcare and Janssen. The study was published in the Clinical Cardiology. The study claimed that the risk of serious bleeding was consistent with those from the clinical study used to approve Xarelto. Namely, the study assessed 27,467 patients who were taking Xarelto (Rivaroxaban) from January 2013 to March 2014. It reported that 478 patients suffered a major bleed event, and 14 patients died from such internal bleeding.

What Are The Grounds For A Xarelto Lawsuit?

The majority of lawsuits filed by plaintiffs to date all allege similar allegations against Xarelto. Namely, the drug was prescribed to prevent blood clots and due to the nature of how Xarelto operates subsequently lead to an uncontrollable bleeding event which caused serious injury and/or death.

The lawsuits filed make the following allegations as the basis for their Xarelto lawsuits:

  • Xarelto manufacturers failed to warn about the risks of Xarelto, specifically the irreversible uncontrollable bleeding that may occur in some patients
  • Xarelto contained a design defect in that it did not safely provide an anti coagulation solution, but instead posed greater risks to patients of internal bleeding due to no reversal agent
  • Xarelto fraudulently concealed knowledge of irreversible life threatening events and how doctors should intervene and stabilize patients
  • Xarelto manufacturers were negligent in placing the drug into the marketing knowing there was no antidote
  • Xarelto manufacturers made a negligent misrepresentation in marketing Xarelto as a safe blood thinner
  • Xarelto did not provide benefits greater than products that already existed in the marketplace in a safer manner such as Warfarin

Below will be an updated feed of information on each Xarelto lawsuit filed, with a summary of the allegations, injuries and demands of the parties.

What Is A Xarelto Wrongful Death Lawsuit?

Medical ppares and stethoscopeUnfortunately, due to the severe injuries caused by serious internal bleeding, many patients who took Xarelto and suffered such a bleed often die. As a result, the estate and family of the deceased may have a right to bring a Xarelto wrongful death lawsuit against the manufacturers of the drug.

To date, there have been several such Xarelto wrongful death lawsuits. A wrongful death lawsuit is a claim brought by the immediate spouse/family of the decedent that seeks compensation for:

  • medical expenses that were incurred to treat the deceased
  • funeral and burial expenses
  • loss of earnings and financial support while the decedent was treating, and of course future losses due to death

If you lost a loved one due to an internal bleeding event that you believe was caused by Xarelto, then call our Xarelto lawyers today. We understand the emotions you will be going through. We know you have medical, funeral, and economic losses to deal with along with emotional strain and grief of loving a loved one. We can advise you as to your rights and whether you can bring a Xarelto wrongful death lawsuit against the manufacturers.

What Is The Statute Of Limitations For Xarelto Lawsuits?

The statute of limitations is a defense that may be raised by defendants in a Xarelto lawsuit. The statute requires that a claim must be brought within a specific time frame of when the event occurred or should have been discovered. The statute of limitations will vary from state to state, so there is no one rule that applies to all cases. Below is an example of the statute as it applies to specific states:

  1. Pennsylvania Defective Products Statute Of Limitations:
         – an action must be brought within 2 years from the date of injury
  2. New Jersey Defective Products Statute Of Limitations:
         – an action must be brought within 2 years from the date of injury
  3. California Defective Products Statute Of Limitations:
         – an action must be brought within 2 years from the date of injury
  4. New York Defective Products Statute Of Limitations:
         – an action must be brought within 3 years from the date of injury
  5. District Of Columbia (D.C.) Defective Products Statute Of Limitations:
         – an action must be brought within 3 years from the date of injury

If you have questions about the statute of limitations as it relates to a potential Xarelto lawsuit, then call our lawyers today. We will assess your specific circumstances and determine whether the statute of limitations will be a problem or not. It is important to speak with an experienced defective products attorney about your potential case as soon as possible to avoid being barred from filing a lawsuit by the statute of limitations.

How Much Can I Get For A Xarelto Lawsuit Settlement?

To date, there has not been a Xarelto lawsuit settlement. In fact, trials have not yet begun. Since these cases are being filed as individual personal injury lawsuits, it is impossible at this point to determine how much a xarelto lawsuit will settle for. Circumstances can vary greatly from case to case.

Each lawsuit will contain economic and non-economic damages. Economic damages involve treatment costs, medical expenses, long-term/future care, funeral/burial expenses, loss of earnings, and loss of future income claims. Non-economic damages will involve the pain and suffering for the injuries, and/or the pain and suffering for the loss of consortium/companionship. Our lawyers work with experienced experts and actuaries to determine the economic and non-economic damages for each case.

However, in May 2014 a blood thinner similar to Xarelto, settled cases that were similar in nature to the current Xarelto litigation. In that settlement, Boehringer Ingelheim settled 4,000 lawsuits against its blood thinner Pradaxa for $650 million dollars. It remains to be seen how the Xarelto litigation will conclude, however we will be following and reporting on any settlement as soon as information becomes available.

Why Should I File A Xarelto Lawsuit?

Favicon!Depending on the injury suffered from internal bleeding, you are likely facing increasing medical expenses, loss of earnings, and if you lost a loved one you will have had to bear funeral, burial and future loss of income expenses. These losses could have been avoided had you or your loved one known about the irreversible bleeding risks associated with Xarelto. While no amount of financial compensation can bring back the loss of a loved one or return you to a prior position, it will allow you to recover without financial stress.

Call our experienced Xarelto lawyers today. We will guide you through the process and represent your best interests.

Latest Xarelto Blood Thinner News

Michael Monheit - Personal Injury Lawyer
Found below is relevant information about injuries and lawsuits associated with the drug Xarelto.

December 19th, 2017 – Plaintiff In 1st Philadelphia Trial Wins

On December 6th, 2017, the first Philadelphia Xarelto lawsuit to go to trial concluded with the judge siding with the plaintiff and awarding them nearly $28 million. This is the first victory for a plaintiff in the ongoing Xarelto litigation and has offered the plaintiffs who continue to wait for their turn some hope.

November 22nd, 2017 – First Philadelphia Lawsuit Underway

The first of around 1,500 lawsuits which make up a mass tort in Philadelphia, PA has finally gone to trial and plaintiffs are eagerly awaiting the outcome. It has been reported that a former FDA Commissioner will testify on the plaintiff’s behalf about the risks of using Xarelto.

October 9th, 2017 – New Study Shows Increased Bleeding Risk

On October 3rd, 2017, a new study published in the Journal of American Medical Association (JAMA) showed that when researchers in Taiwan reviewed the files of 91,000 patients who were prescribed blood thinners, they found that those who took anti-fungal medications with Xarelto were more likely to suffer a major bleeding event.

September 27, 2017- Retrials Being Filed For Xarelto Bellwether Cases

Plaintiff lawyers from the recent trio of bellwether cases in the federal multi-district litigation of the blood thinner drug Xarelto are filing motions to seek retrials. They believe that newly released evidence is contradictory to the cases’ courtroom testimony and it may have swayed the jury to find for the clients. The August trial had a seven-person jury from the U.S. District Court for the Southern District of Mississippi, that decided Bayer and Janssen Pharmaceuticals were not responsible for the internal bleeding and anemia suffered by a 69-year-old woman from Summit, Mississippi.

August 22, 2017- Bayer, Johnson & Johnson Win Third Xarelto Litigation

Bayer and Johnson and Johnson now have three wins in lawsuits involving the bleeding risks caused by Xarelto. The latest case was won in a federal court in Mississippi where a jury favored the drugmaker in a lawsuit brought forward by a woman who stated she developed acute gastrointestinal bleeding after using Xarelto. She started using the drug after an operation in 2015. Bayer and Johnson and Johsnon have stated that they will continue to defend the drug against legal attacks. Currently the drugmakers are facing over 18,600 lawsuits in both state and federal courts.

July 17, 2017- 15,000 Adverse Events Linked To Xarelto In 2016

According to the Institute for Safe Medication Practices (ISMP) recent QuarterWatch Report, Xarelto far outpaced the number of serious adverse effects suffered by patients in comparison to other drugs in this class. There were over 21,000 severe injuries in 2016 that were a result of blood-thinning medications and over 3,000 deaths linked to them. Of these totals, Xarelto was responsible for roughly 15,000 negative effects. The ISMP report took into consideration “notable signals of significant drug risk” as stated in the U.S. Food and Drug Administration’s side effects database.

June 8, 2017- Warning From ISMP About Using Aspirin With Xarelto

The Institute of Safe Medication Practices (ISMP) recently released their QuarterWatch report for the third quarter of 2016, where they state findings of an increase aspirin-related bleeding events. ISMP believes these events are linked to the use of Xarelto and aspirin. After noticing an “unexpectedly large number” of severe drug events in connection with aspirin, researchers found that aspirin was often used in conjunction with other drugs that inhibit blood clots, such as Xarelto. It was noted that the combination of drugs that are likely to reduce blood clotting creates a high risk of bleeding. ISMP stated that the long-term use of drugs such as Xarelto is likely to cause bleeding in 10-15 percent of patients per year, as well as life-threatening hemorrhages in two to four percent of patients.

May 30, 2017- Xarelto Win Has No Bearing On Remaining 18,000 Lawsuits

Recently, Bayer Pharmaceuticals and Johnson & Johnson won their first Xarelto federal trial. However, this win should have no bearing on the remaining lawsuits. There are currently more than 16,000 cases still pending in the federal multidistrict litigation, including nearly 1,400 cases that have been filed in a mass tort program that are now underway in Pennsylvania’s Philadelphia Court of Common Pleas. Each Xarelto case will be decided on its specific merits. Bellwether trials will continue as scheduled in the federal multidistrict litigation.

April 28, 2017- Part Time Security Guard Says Using Xarelto Was A Bad Decision

A part-time security guard who used Johnson & Johnson’s blood-thinning drug Xarelto, claims that using the drug was one of the worst mistakes of his life. He was using Xarelto to help lower his risk of suffering a stroke, instead, the drug caused him to have internal bleeding that required him to stay in hospital for a week in the intensive care unit. He also endured several blood transfusions and multiple heart procedures. His ordeal has left him cautioning other people to not have to suffer like he did from using this drug. Very soon the security guard will have a chance to have jurors hold J&J and Bayer accountable for the drug’s potentially fatal side effects. He filed a lawsuit in New Orleans which becomes the first lawsuit to target the drug and is subsequently going to trial.

March 24, 2017- Johnson & Johnson Faces Over 11,000 Lawsuits & Physician Bribes

It has been reported that Johnson & Johnson spent $28.4 million in physician bribes during 2015. These bribes are being reported at a time when the pharmaceutical company is facing over 15,000 lawsuits alleging that the company failed to warn patients and doctors about the dangers associated with Xarelto. Doctors were bribed to write prescriptions for Xarelto and the drug was at the top of ProPublica’s “Dollars for Docs” list in 2015. The ProPublica’s analysis data reveals that the more money a doctor gets from a drug company, the more likely the doctor is to prescribe that company’s brand name products.

February 24, 2017- Xarelto Bellwether Pushed Back Due To NBA All-Star Game

The maiden bellwether Xarelto Lawsuit that was scheduled to originally start in February in New Orleans, has been rescheduled. The bellwether is an important one due to the number of Xarelto bleeding issue cases that are now over 10,000. The push back is due to an NBA All-Star game which was being held in New Orleans. The event took place February 17th to 19th and it was decided to push the start of the first Xarelto bellwether lawsuit to March. The first bellwether is now scheduled for March 13 in the Eastern District of Louisiana and the second bellwether trial is scheduled for April 24.

January 27, 2017- Study Reveals That Xarelto Has A Higher Bleeding Rate Than Other Drugs

A study published in the medical journal Gastroenterology conducted by the Mayo Clinic revealed that Xarelto has a higher bleeding rate than its competitors. The researchers who conducted the study examined the effects of three anticoagulants; Xarelto, Eliquis, and Pradaxa. It was concluded that Xarelto had more incidents of gastrointestinal bleeding than the other two drugs. Data for this study examined approximately 57,000 patients with non-valve atrial fibrillation who were prescribed Xarelto, Eliquis or Pradaxa from October 1, 2010, to February 28, 2015, and had experienced gastrointestinal bleeding.

December 21, 2016- MDL Bellwether Selection Process Adopted For Xarelto Mass Tort

The Philadelphia Court of Common Pleas has indicated that parties who filed Xarelto lawsuits in January 2015, will go through a process similar to the one used in multidistrict litigation to choose early bellwether trials. Instead of giving priority to the cases that were filed first, the court is going to create a discovery pool of cases. The pool is where a final few will be chosen for trial.

November 30, 2016- Xarelto Lawsuit Updates

There have been over 9,000 lawsuits filed all over the United States against the manufacturers and distributors of Xarelto. To date, there are more than 7,000 lawsuits pending in New Orleans, Louisiana in the multi-district MDL, which is overseen by U.S. District Court Judge Eldon Fallon. In Pennsylvania, there are nearly 1,000 pending state court cases, 1,000 lawsuits filed in Delaware and more cases in California state courts.

October 18, 2016- Study Shows Xarelto Causes More Serious Bleeding Than Pradaxa

According to a study published in JAMA Internal Medicine, patients on Xarelto are more likely to suffer serious bleeding incidents than patients using Pradaxa. The observational study was conducted on 118,000 Medicare patients with atrial fibrillation using one of the two medications. Those taking Xarelto had significant increases in intracerebral hemorrhage and major extracranial bleeding.

September 21, 2016- Xarelto Antidote Rejected By The FDA

The Food And Drug Administration (FDA) did not approve Portola Pharmaceuticals’ antidote for uncontrolled bleeding associated with blood thinners like Xarelto. Portola’s drug called AndexXa was granted an expedited review by the FDA. However, the agency stated that it needs more information before this antidote can be approved. The FDA will revisit the antidote approval review once Portola submits more information including how it is manufactured.

August 31, 2016- Xarelto Litigation Consolidates Over Five Thousand Lawsuits

Almost 6,000 Xarelto lawsuits have been consolidated for pretrial proceedings as Xarelto plaintiffs wait to see if a bellwether trial will be heard. More lawsuits continue to be filed regularly. Bellwether cases will determine the future of Xarelto litigation. The Judicial Panel on Multidistrict Litigation has stated that as of June 15, 2016, more than 5,853 lawsuits have been consolidated for pretrial proceedings in MDL 2592.

June 30, 2016- Ohio Couple Alleges Xarelto Caused Damages And Anemia

An Ohio couple has filed a lawsuit against the makers of Xarelto- Janssen Pharmaceuticals and Bayer AG, alleging that the wife suffered a potentially life-threatening intestinal bleed, anemia, and other complications as a result of using Xarelto. The complications the wife suffered have hindered her from living life to the full. The couple is seeking over $150,000 in damages so that they can cover their medical costs as well as future expenses. Xarelto complications were suffered by the wife just two months after she started using the drug as prescribed by her doctor.

May 31, 2016- Xarelto Lawsuits Might Follow Pradaxa Claims Path

With the accumulation of Xarelto lawsuits, some experts are predicting that the future of these Xarelto claims might end up the way Pradaxa claims ended. Pradaxa is a similar blood thinner manufactured by Boehringer Ingelheim and like Xarelto it has been accused of causing uncontrollable bleeding. In 2014, the Pradaxa drug maker settled all state and federal lawsuits for $650 million. Although Xarelto claims seem to be headed down the same path, experts say it is also too early to predict their fate despite the Pradaxa similarities.

April 22, 2016- Canadian Xarelto Lawsuits Are Increasing

As Xarelto lawsuits are increasing in the US, the same is happening in Canada. Health Canada which is the equivalent of the US Food and Drug Administration (FDA), has registered 1,100 Xarelto related side effects since February 2015. A few of those registered cases resulted in death due to the usage of Xarelto. Canadian lawyers dealing with Xarelto cases are expecting to file another Xarelto related lawsuit involving  an 83-year-old Ontario woman who is stated to have bled to death in the shower.

wrongful death

March 31, 2016- Xarelto Class Action Lawsuit Filed In Calgary Canada For Uncontrollable Bleeding

A class action lawsuit has been filed against Bayer Inc. in Calgary, Canada. The plaintiff in this Canadian lawsuit has stated that the drug Xarelto, manufactured by Bayer Inc. led her to experience an uncontrollable bleeding episode that almost caused her to be in cardiac arrest. This Canadian class action lawsuit follows the already established Multidistrict Litigation number 2592 in America, which includes a group of over 2,800 cases filed against Xarelto.

February 18, 2016- Thousands Of Individual Lawsuits Pending In State And Federal Courts

In the latest Xarelto national cases, there are nearly 5,000 individual lawsuits that are pending in state and federal courts filed against the manufacturers of the drug. Majority of the state court lawsuits are in Philadelphia.There are almost 600 individual lawsuits pending in Philadelphia. Currently, hundreds more lawsuits are expected to be filed in the coming months, primarily because Xarelto is still on the market and patients and doctors are not aware of the safety concerns regarding the drug.

January 26, 2016- Ohio Man Files Xarelto Lawsuit For Permanent Injuries

A man from Cincinnati, Ohio filed a Xarelto lawsuit stating that usage of the drug led to him having permanent personal injuries. The man started using the drug in May 2014 following his doctor’s orders to use Xarelto for deep vein thrombosis (DVT).

He was later taken to hospital after he started vomiting blood, following several months of Xarelto usage. It was found that he had a gastrointestinal bleed. He is suing because he believes the manufacturers should have done more to protect consumers.

Blood Thinner Logo
Call Now Button